Document Status

This document has been corrected

Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

10.1186/s13569-019-0114-5

Published Online: 2019-04-02

Journal: Clinical Sarcoma Research•Publisher: Springer Science and Business Media LLC

Authors: Denisse Montoya•Jerry W. Call•Michael C. Heinrich•Norman J. Scherzer•Yu Wang

This document has been corrected

Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

10.1186/s13569-019-0114-5

Published Online: 2019-04-02

Journal: Clinical Sarcoma Research

Authors: Denisse Montoya•Jerry W. Call•Michael C. Heinrich•Norman J. Scherzer•Yu Wang

NOW

2019-05-07•Correction

Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

10.1186/s13569-019-0117-2

* information provided by CrossRef

2019-05-07•Correction

10.1186/s13569-019-0117-2

* information provided by CrossRef

2019-04-02•Published